These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7636873)

  • 1. Aminoalkylindoles: structure-activity relationships of novel cannabinoid mimetics.
    Eissenstat MA; Bell MR; D'Ambra TE; Alexander EJ; Daum SJ; Ackerman JH; Gruett MD; Kumar V; Estep KG; Olefirowicz EM
    J Med Chem; 1995 Aug; 38(16):3094-105. PubMed ID: 7636873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
    Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
    J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
    Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
    J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles.
    Jansen EM; Haycock DA; Ward SJ; Seybold VS
    Brain Res; 1992 Mar; 575(1):93-102. PubMed ID: 1504787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor?
    Ward SJ; Baizman E; Bell M; Childers S; D'Ambra T; Eissenstat M; Estep K; Haycock D; Howlett A; Luttinger D
    NIDA Res Monogr; 1990; 105():425-6. PubMed ID: 1908557
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.
    Aung MM; Griffin G; Huffman JW; Wu M; Keel C; Yang B; Showalter VM; Abood ME; Martin BR
    Drug Alcohol Depend; 2000 Aug; 60(2):133-40. PubMed ID: 10940540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of aminoalkylindole binding: selective displacement by cannabinoids.
    Haycock DA; Kuster JE; Stevenson JI; Ward SJ; D'Ambra T
    NIDA Res Monogr; 1990; 105():304-5. PubMed ID: 1876020
    [No Abstract]   [Full Text] [Related]  

  • 8. The third transmembrane helix of the cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, peripheral cannabinoid receptor.
    Chin CN; Murphy JW; Huffman JW; Kendall DA
    J Pharmacol Exp Ther; 1999 Nov; 291(2):837-44. PubMed ID: 10525107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative aminoalkylindoles (AAI) antagonists.
    Casiano FM; Arnold R; Haycock D; Kuster J; Ward SJ
    NIDA Res Monogr; 1990; 105():295-6. PubMed ID: 1876017
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
    Stark S; Pacheco MA; Childers SR
    Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).
    Dutta AK; Ryan W; Thomas BF; Singer M; Compton DR; Martin BR; Razdan RK
    Bioorg Med Chem; 1997 Aug; 5(8):1591-600. PubMed ID: 9313864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoalkylindoles (AAIs): structurally novel cannabinoid-mimetics.
    Eissenstat MA; Bell MR; D'Ambra TE; Estep KG; Haycock DA; Olefirowicz EM; Ward SJ
    NIDA Res Monogr; 1990; 105():427-8. PubMed ID: 1876061
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of analogs of indole-based cannabimimetic agents.
    Mazzoni O; Diurno MV; di Bosco AM; Novellino E; Grieco P; Esposito G; Bertamino A; Calignano A; Russo R
    Chem Biol Drug Des; 2010 Jan; 75(1):106-14. PubMed ID: 19895505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids.
    Xie XQ; Eissenstat M; Makriyannis A
    Life Sci; 1995; 56(23-24):1963-70. PubMed ID: 7776820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids.
    Kuster JE; Stevenson JI; Ward SJ; D'Ambra TE; Haycock DA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1352-63. PubMed ID: 8450470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
    Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM; Paria BC; Dey SK
    Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits.
    Hodges LC; Reggio PH; Green K
    Ophthalmic Res; 1997; 29(1):1-5. PubMed ID: 9112260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens.
    Pertwee RG; Griffin G; Lainton JA; Huffman JW
    Eur J Pharmacol; 1995 Sep; 284(3):241-7. PubMed ID: 8666005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AM630, a competitive cannabinoid receptor antagonist.
    Pertwee R; Griffin G; Fernando S; Li X; Hill A; Makriyannis A
    Life Sci; 1995; 56(23-24):1949-55. PubMed ID: 7776818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.